A major breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently lost in several forms of malignancies, https://socialskates.com/story23425926/mini-antibodies-reactivate-p53-new-new-pathway-for-cancer-management